Skip to main content
SpringerLink
Log in

Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia—a national inpatient sample analysis

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Data are available per reasonable request from the corresponding author.

References

  1. Acute myeloid leukemia [AML] in adults 2023 [Available from: https://www.cancer.org/cancer/types/acute-myeloid-leukemia.html

  2. Newell LF, Cook RJ (2021) Advances in acute myeloid leukemia. BMJ [Clin Res ed] 375:n2026

    PubMed  Google Scholar 

  3. Zeidan AM, Podoltsev NA, Wang X, Zhang C, Bewersdorf JP, Shallis RM et al (2020) Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States. Blood Adv 4(8):1615–1623

    Article  PubMed  PubMed Central  Google Scholar 

  4. HCUP National Inpatient Sample [NIS]. Healthcare cost and utilization project [HCUP]. 2016, 2017, 2018, 2019, 2020. Agency for Healthcare Research and Quality, Rockville, MD. 2022 [Available from: https://www.hcup-us.ahrq.gov/nisoverview.jsp

  5. Cram P, Hillis SL, Barnett M, Rosenthal GE (2004) Effects of weekend admission and hospital teaching status on in-hospital mortality. Am J Med 117(3):151–157

    Article  PubMed  Google Scholar 

  6. Mohammad Ammad U, Din HS, Shahzad M, Liaqat H, Sweet K (2023) The impact of mild-to-moderate chronic kidney disease on hospitalization outcomes in patients with acute myeloid leukemia. Leukem Lympho 64(5):1040–1044. https://doi.org/10.1080/10428194.2023.2190435

    Article  Google Scholar 

  7. Tawfik B, Pardee TS, Isom S, Sliesoraitis S, Winter A, Lawrence J, Powell BL, Klepin HD (2016) Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML). J Geriatr Oncol 7(1):24–31. https://doi.org/10.1016/j.jgo.2015.10.182

    Article  PubMed  Google Scholar 

  8. Ali NA, O'Brien JM Jr, Blum W, Byrd JC, Klisovic RB, Marcucci G, Phillips G, Marsh CB, Lemeshow S, Grever MR (2007) Hyperglycemia in patients with acute myeloid leukemia is associated with increased hospital mortality. Cancer 110:96–102. https://doi.org/10.1002/cncr.22777

    Article  PubMed  Google Scholar 

  9. Ballo O, Eladly F, Büttner S, Stratmann JA, Rudolf S, Brunnberg U et al (2021) Acute kidney injury adversely affects the clinical course of acute myeloid leukemia patients undergoing induction chemotherapy. Ann Hematol 100(5):1159–1167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Petrone G, Handa S, Gupta K, Khan A, Rajeeve S (2019) Acute myeloid leukemia and cirrhosis: trends in utilization of induction chemotherapy, rate of hospitalizations and mortality. Blood. 134(Supplement_1):3864

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Willis Knighton Health System, Shreveport, LA, USA

    Saloni Savani

  2. Louisiana State University Health Shreveport, Shreveport, LA, USA

    Suma Sri Chennapragada

  3. Triolet, Mauritius

    Kamleshun Ramphul

  4. Danbury Hospital, Yale Affiliated Hospitals Program, Danbury, CT, USA

    Mehndi Dandwani

  5. Chandigarh, Punjab, India

    Renuka Verma

  6. Sri Manakula Vinayagar Med college and Hosp, Puducherry, India

    Sailaja Sanikommu

  7. Kamineni Academy of Medical Sciences and Research Centre, NTRUHS, Hyderabad, India

    Alekhya Pagidipally

  8. MedStar Health, Columbia, MD, USA

    FNU Arti

  9. University of Mississippi Medical Center, Jackson, MS, USA

    Vijay Kumar

  10. Bharati Vidyapeeth Univ Med College and Hosp, Hyderabad, India

    Shaheen Sombans

  11. SSRN Hospital, Pamplemousses, Mauritius

    Yogeshwaree Ramphul

  12. Santo Domingo, Dominican Republic

    Stephanie G. Mejias

  13. Brampton, ON, Canada

    Balkiranjit Kaur Dhillon

  14. Jacobi Medical Centre, Bronx, NY, USA

    Petras Lohana

  15. Department of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA, USA

    Shivani Sharma

Authors
  1. Saloni Savani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suma Sri Chennapragada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kamleshun Ramphul
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehndi Dandwani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Renuka Verma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sailaja Sanikommu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Alekhya Pagidipally
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. FNU Arti
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Vijay Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Shaheen Sombans
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yogeshwaree Ramphul
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Stephanie G. Mejias
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Balkiranjit Kaur Dhillon
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Petras Lohana
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Shivani Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by KR. The first draft of the manuscript was written by SS and SSC. All authors commented on previous versions of the manuscript. SS performed project supervision. All authors made significant contributions to writing the manuscript and read and approved the final manuscript.

Corresponding author

Correspondence to Saloni Savani.

Ethics declarations

Ethics approval

National Inpatient Sample data is released in a de-identified form by the Healthcare Cost and Utilization Project (HCUP0. The provider further waives users of all ethical and IRB approvals. Additional information can be found at https://hcup-us.ahrq.gov/nisoverview.jsp.The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Savani, S., Chennapragada, S.S., Ramphul, K. et al. Factors associated with inpatient mortality during daunorubicin and cytarabine induction in adults with acute myeloid leukemia—a national inpatient sample analysis. Ann Hematol 103, 663–665 (2024). https://doi.org/10.1007/s00277-023-05505-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05505-x

Search

Navigation